Page last updated: 2024-08-26

arsenic and Hematologic Diseases

arsenic has been researched along with Hematologic Diseases in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19907 (46.67)18.7374
1990's0 (0.00)18.2507
2000's5 (33.33)29.6817
2010's3 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ardalan, B; Subbarayan, PR1
Bazarbachi, A; de Thé, H; El Hajj, H; Farid, R; Hatoum, H; Hermine, O; Kchour, G; Kooshyar, MM; Mahmoudi, M; Maleki, M; Rafatpanah, H; Rahimi, H; Rezaee, SA; Shirdel, A; Tarhini, M; Wattel, E; Yazdi, MT1
Shan, Y1
Ma, H; Wang, C; Wang, XF; Wang, Y1
Bosly, A; Bowen, D; Burnett, A; Casadevall, N; Dennis, M; Dombret, H; Dreyfus, F; Fenaux, P; Feremans, W; Guerci, A; Legros, L; Ribrag, V; Vey, N1
Douer, D; Hainsworth, JD; List, AF; Mason, J; Rizzieri, D; Saleh, M; Schiller, GJ; Slack, J1
Winship, KA1
Doll, DC; Patterson, WP; Perry, MC; Ringenberg, QS; Yarbro, JW1
Abdul, KS; Chandana, EP; De Silva, PM; Jayasinghe, SS; Jayasumana, C1
Li, L; Ma, R1
MARCHAL, G1
Roberts, HJ1
Hine, CH; Nelson, KW; Pinto, SS1
Waldron, HA1

Reviews

5 review(s) available for arsenic and Hematologic Diseases

ArticleYear
In the war against solid tumors arsenic trioxide needs partners.
    Journal of gastrointestinal cancer, 2014, Volume: 45, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Brain Diseases; Clinical Trials as Topic; Combined Modality Therapy; Drug Approval; Drug Synergism; Hedgehog Proteins; Hematologic Diseases; Humans; Medicine, Chinese Traditional; Neoplasm Proteins; Neoplasms; Oncogene Proteins, Fusion; Oxides; Radiotherapy, Adjuvant; Signal Transduction; Thymidylate Synthase; Transcription Factors; Treatment Outcome; United States; United States Food and Drug Administration; Zinc Finger Protein GLI1

2014
Toxicity of inorganic arsenic salts.
    Adverse drug reactions and acute poisoning reviews, 1984,Autumn, Volume: 3, Issue:3

    Topics: Acute Disease; Arsenic; Arsenic Poisoning; Arsenicals; Biotransformation; Carcinogens; Central Nervous System Diseases; Chemical and Drug Induced Liver Injury; Chemistry; Chronic Disease; Digestive System; Hematologic Diseases; Hemodynamics; History, 18th Century; History, 19th Century; History, 20th Century; History, Ancient; Humans; Intestinal Absorption; Kidney Diseases; Mutagens; Nervous System Diseases; Skin Diseases; Teratogens; Tissue Distribution

1984
Hematologic effects of heavy metal poisoning.
    Southern medical journal, 1988, Volume: 81, Issue:9

    Topics: Anemia; Arsenic Poisoning; Arsenicals; Copper; Diagnosis, Differential; Gold; Hematologic Diseases; Humans; Lead Poisoning; Metals; Occupational Diseases; Zinc

1988
Arsenic and human health effects: A review.
    Environmental toxicology and pharmacology, 2015, Volume: 40, Issue:3

    Topics: Arsenic; Cardiovascular Diseases; Environmental Exposure; Epigenesis, Genetic; Hematologic Diseases; Humans; Immune System Diseases; Mutation; Neoplasms; Nervous System Diseases; Respiratory Tract Diseases

2015
Target organs. The blood.
    The Journal of the Society of Occupational Medicine, 1979, Volume: 29, Issue:2

    Topics: Arsenic; Benzene; Blood Physiological Phenomena; Bone Marrow; Erythrocytes; Female; Globins; Hematologic Diseases; Heme; Humans; Lead; Leukemia, Radiation-Induced; Male; Occupational Diseases; Radiation, Ionizing

1979

Trials

3 trial(s) available for arsenic and Hematologic Diseases

ArticleYear
Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).
    Blood, 2009, Jun-25, Volume: 113, Issue:26

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Synergism; Female; Gastrointestinal Diseases; Hematologic Diseases; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Oxides; Proviruses; Remission Induction; Viral Load; Zidovudine

2009
Arsenic trioxide in patients with myelodysplastic syndromes: a phase II multicenter study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Jun-01, Volume: 24, Issue:16

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Disease-Free Survival; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Myelodysplastic Syndromes; Oxides; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Survival Analysis; Treatment Outcome

2006
Phase II multicenter study of arsenic trioxide in patients with myelodysplastic syndromes.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Jun-01, Volume: 24, Issue:16

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Disease-Free Survival; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Myelodysplastic Syndromes; Oxides; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Survival Analysis; Treatment Outcome

2006

Other Studies

7 other study(ies) available for arsenic and Hematologic Diseases

ArticleYear
[Hematology].
    Zhonghua yi xue za zhi, 2002, Dec-25, Volume: 82, Issue:24

    Topics: Arsenic Trioxide; Arsenicals; Biomedical Research; China; Hematologic Diseases; Hematology; Humans; Oxides

2002
Simultaneously multi-parameter determination of hematonosis cell apoptosis by two-photon and confocal laser scanning microscopy.
    Journal of clinical laboratory analysis, 2004, Volume: 18, Issue:5

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Calcium; Cell Line, Tumor; Cell Nucleus; Dose-Response Relationship, Drug; Flow Cytometry; Hematologic Diseases; Humans; Leukemia; Membrane Potentials; Microscopy, Confocal; Mitochondria; Oxides; Photons

2004
[Clinical application of professor MA Rou's experience in treating hematological disease by arsenic-containing Chinese herbal medicine].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2011, Volume: 31, Issue:8

    Topics: Arsenic; Drugs, Chinese Herbal; Hematologic Diseases; Humans; Phytotherapy

2011
[Radioactive phosphorus and radioactive arsenic in the treatment of malignant blood diseases].
    La Revue du praticien, 1952, Sep-21, Volume: 2, Issue:24

    Topics: Arsenic; Hematologic Diseases; Hodgkin Disease; Humans; Leukemia; Phosphorus; Polycythemia Vera; Radioisotopes

1952
[Treatment of malignant hemopathy with radioactive phosphorus and arsenic].
    Resenha clinico-cientifica, 1953, Volume: 22, Issue:6

    Topics: Arsenic; Hematologic Diseases; Phosphorus; Phosphorus Radioisotopes; Phosphorus, Dietary; Radioactivity; Radioisotopes

1953
Potential toxicity due to dolomite and bonemeal.
    Southern medical journal, 1983, Volume: 76, Issue:5

    Topics: Adult; Aged; Arsenic; Biological Products; Bone and Bones; Calcium; Calcium Carbonate; Child; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Lead; Magnesium; Male; Mercury; Middle Aged; Minerals; Nervous System Diseases; Pregnancy; Skin Diseases; Spectrophotometry, Atomic; Vitamins

1983
Medical problems associated with arsenic exposure.
    Journal of occupational medicine. : official publication of the Industrial Medical Association, 1977, Volume: 19, Issue:6

    Topics: Arsenic; Arsenic Poisoning; Chemical and Drug Induced Liver Injury; Dermatitis, Occupational; Heart Diseases; Hematologic Diseases; Humans; Kidney Diseases; Metallurgy; Neoplasms; Neurologic Manifestations; Occupational Diseases; Respiratory Tract Diseases; Washington

1977